MAPK3 and breast cancer: In human breast cancer cells, GPR30 was found to be necessary for BPA-induced activation of Erk1/2, cell proliferation and migration, and transcriptional regulation of genes (c-fos, EGR-1, and CTGF) independent of ERα/β-mediated signaling [36,41].